BT-117

N/A

Report date: 2025/11/20 16:04:47

NME

Base Information

Drug NameBT-117

Drug Alias NameBT-117

ClassificationRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Nuclides > Lutetium > 177LuRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionIonising radiation emittersProstate-Specific Membrane Antigen modulatorsIntegrin alpha-V/beta-3 antagonists

TargetsProstate-Specific Membrane AntigenIntegrin alpha-V/beta-3

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesChengdu Brilliant Pharmaceutical Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesChengdu Brilliant Pharmaceutical Co Ltd

Inactive CompaniesN/A

Active IndicationsProstatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A